n-hydroxyphthalimide has been researched along with Breast Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Butura, M; Coroaba, A; Luta, G; Stan, CS; Stanciu, GD; Tiron, A; Tiron, CE; Ursu, EL; Zugun-Eloae, F | 1 |
1 other study(ies) available for n-hydroxyphthalimide and Breast Cancer
Article | Year |
---|---|
NHF-derived carbon dots: prevalidation approach in breast cancer treatment.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carbon; Cell Line, Tumor; Cell Movement; Cell Survival; Chaperonin 60; Female; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mitochondrial Proteins; Neoplasm Invasiveness; Neoplasm Metastasis; Phthalimides; Quantum Dots; Xenograft Model Antitumor Assays | 2020 |